Mutant P53 Is a Key Determinant of Ovarian Cancer

被引：0
|
作者：
Mullany, Lisa K. [1 ]
Ren, Yi [2 ]
Marciano, David C. [2 ]
Wong, Kwong-Kwok [3 ]
King-Crane, Erin R. [3 ]
Katsonis, Panagiotis [2 ]
Liu, Zhilin [2 ]
Lichtarge, Olivier [2 ]
Richards, JoAnne S. [2 ]
机构：
[1] Baylor Coll Med, MCB, Houston, TX 77030 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
MON-0316
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Some aspects of mutant p53 in ovarian cancer biology
    Heublein, Sabine
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S546 - S547
  • [2] Mutant p53 enhances the metastatic potential of ovarian cancer cells
    Ahn, Ji-Hye
    Lee, Jong-Gyu
    Choi, Jung-Hye
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Clinical trials with p53 tumor suppressor gene for p53-mutant ovarian cancer
    Pegram, MD
    Runnebaum, I
    Buekers, T
    Konecny, G
    Karlan, BY
    Chan, D
    Slamon, DJ
    Horowitz, J
    Buller, R
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S33 - S33
  • [4] Mutant p53 in colon cancer
    Nakayama, Mizuho
    Oshima, Masanobu
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2019, 11 (04) : 267 - 276
  • [5] Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53
    Ramraj, Satish K.
    Elayapillai, Sugantha P.
    Pelikan, Richard C.
    Zhao, Yan D.
    Isingizwe, Zitha R.
    Kennedy, Amy L.
    Lightfoot, Stanley A.
    Benbrook, Doris M.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (04) : 1086 - 1097
  • [6] Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
    Sonego, Maura
    Schiappacassi, Monica
    Lovisa, Sara
    Dall'Acqua, Alessandra
    Bagnoli, Marina
    Lovat, Francesca
    Libra, Massimo
    D'Andrea, Sara
    Canzonieri, Vincenzo
    Militello, Loredana
    Napoli, Marco
    Giorda, Giorgio
    Pivetta, Barbara
    Mezzanzanica, Delia
    Barbareschi, Mattia
    Valeri, Barbara
    Canevari, Silvana
    Colombatti, Alfonso
    Belletti, Barbara
    Del Sal, Giannino
    Baldassarre, Gustavo
    EMBO MOLECULAR MEDICINE, 2013, 5 (05) : 707 - 722
  • [7] Targeting mutant p53 and cell-cell adhesion in ovarian cancer
    Iwanicki, Marcin P.
    Novak, Marian
    Zervantonakis, Ioannis K.
    Ince, Tan A.
    Drapkin, Ronny
    Brugge, Joan S.
    CLINICAL CANCER RESEARCH, 2013, 19
  • [8] Targeting mutant p53: a key player in breast cancer pathogenesis and beyond
    Qayoom, Hina
    Ul Haq, Burhan
    Sofi, Shazia
    Jan, Nusrat
    Jan, Asma
    Mir, Manzoor A.
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [9] Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
    G Hofstetter
    A Berger
    E Schuster
    A Wolf
    G Hager
    I Vergote
    I Cadron
    J Sehouli
    E I Braicu
    S Mahner
    P Speiser
    C Marth
    A G Zeimet
    H Ulmer
    R Zeillinger
    N Concin
    British Journal of Cancer, 2011, 105 : 1593 - 1599
  • [10] Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
    Hofstetter, G.
    Berger, A.
    Schuster, E.
    Wolf, A.
    Hager, G.
    Vergote, I.
    Cadron, I.
    Sehouli, J.
    Braicu, E. I.
    Mahner, S.
    Speiser, P.
    Marth, C.
    Zeimet, A. G.
    Ulmer, H.
    Zeillinger, R.
    Concin, N.
    BRITISH JOURNAL OF CANCER, 2011, 105 (10) : 1593 - 1599
12345